RankBoost360

Market Overview The global  irritable bowel syndrome (IBS) treatment market   was valued at USD 3.69 billion in 2023 and is expected to grow at a CAGR of 8.4% during the forecast period. This market is gaining traction as awareness around gastrointestinal disorders, particularly IBS, increases worldwide. IBS is a chronic condition characterized by abdominal pain, bloating, diarrhea, and constipation. The disorder significantly impacts the quality of life and productivity of affected individuals. As medical research advances and healthcare systems prioritize gastrointestinal health, the demand for effective IBS therapies continues to surge. The market is composed of pharmaceutical treatments, dietary management products, and supportive care services aimed at relieving IBS symptoms. Innovations in diagnostics and a growing understanding of gut-brain axis have also encouraged the development of targeted treatment options. The integration of digital therapeutics and personalized m...

  Market Overview The global  intravenous immunoglobulin (IVIG) market   was valued at  USD 12.66 billion in 2023  and is expected to grow at a  CAGR of 7.50% during the forecast period . Intravenous immunoglobulin is a therapeutic preparation made from pooled human plasma, containing a broad spectrum of antibodies. It plays a crucial role in the treatment of primary and secondary immunodeficiency diseases, autoimmune disorders, and various neurological conditions. The increasing prevalence of immune-related diseases and the growing geriatric population are propelling the demand for IVIG globally. Additionally, the increasing use of IVIG therapy in off-label applications, such as for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy, and myasthenia gravis, is expanding its scope across the healthcare sector. With advances in plasma collection technologies, improved purification techniques, and heightened ...

The global  hospital supplies market   was valued at USD 138.23 billion in 2021 and is expected to grow at a CAGR of 3.3% during the forecast period. Driven by increasing healthcare demands, advancements in medical infrastructure, and a growing emphasis on patient care and hygiene, the hospital supplies industry is undergoing a phase of consistent expansion. These trends are also shaped by the rising burden of chronic illnesses, an aging global population, and growing governmental and private sector investments in health systems. Market Overview Hospital supplies are indispensable in the daily operations of healthcare facilities. These supplies encompass a wide range of products including surgical instruments, disposable hospital consumables, diagnostic devices, mobility aids, and sterilization equipment. The demand for such essential tools has been rising in response to a surge in hospitalization rates, especially in the wake of global health emergencies and non-communicable ...

Market Overview The global  rheumatoid arthritis market   was valued at USD 22.77 billion in 2021 and is expected to grow at a CAGR of 4.5% during the forecast period. Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disorder that primarily affects joints but can also damage other body systems. The increasing prevalence of RA worldwide, coupled with advancements in drug development, is fueling demand for effective and targeted treatment options. RA affects approximately 1% of the global population and is more common in women than in men. With the global population aging, the incidence of RA continues to rise, further intensifying the need for early diagnosis and efficient management strategies. The market comprises a variety of treatment modalities including biologics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). Key Market Growth Drivers Rising Prevalence of Rheumatoid Arthritis One of the ...

The global  obesity treatment market   was valued at USD 14.02 billion in 2021 and is expected to grow at a CAGR of 10.1% during the forecast period. This upward trend is driven by increasing obesity prevalence, growing awareness of health risks associated with excess weight, advancements in treatment modalities, and supportive government initiatives. The market is witnessing rapid technological innovations, development of minimally invasive and non-invasive procedures, and strong investments in research and development, which are contributing to market expansion. Market Overview Obesity has emerged as one of the most pressing global health challenges in recent decades, affecting millions of individuals across all age groups. It is not only a physical condition but a complex medical disorder associated with several comorbidities including type 2 diabetes, cardiovascular diseases, and certain forms of cancer. As the global population continues to struggle with sedentary lifesty...